Chlorpromazine and Standard of Care in Glioblastoma
Status:
Not yet recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
This is a phase 1 study investigating the re-purposing of chlorpromazine, combined with
temozolomide and radiation in the treatment of newly diagnosed glioblastoma multiforme.